Patents by Inventor Adrian Mockett

Adrian Mockett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tylvalosin as antiviral agent
    Patent number: 9649324
    Abstract: The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: May 16, 2017
    Assignees: ECO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • USE OF TYLVALOSIN AS ANTIVIRAL AGENT
    Publication number: 20150313929
    Abstract: The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Application
    Filed: June 8, 2015
    Publication date: November 5, 2015
    Applicants: ECO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • Use of tylvalosin as antiviral agent
    Patent number: 9066964
    Abstract: The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: June 30, 2015
    Assignees: Cambridge University Technical Services, Eco Animal Health Limited
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • Trivalent vaccine with maternal anitbody transfer via the milk
    Patent number: 7790178
    Abstract: Embodiments of the present invention generally relate to novel multivalent vaccines and methods of vaccinating. In an embodiment, the present invention is a trivalent vaccine for canine herpesvirus (CHV), canine rotavirus (CRV), and Minute virus of canine (MVC) or other canine parvovirus delivered to pups of a whelp through colostrums and providing sufficient antibody titer to impart protection.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: September 7, 2010
    Assignee: Intervet International B.V.
    Inventors: Thomas Gore, Adrian Mockett
  • USE OF TYLVALOSIN AS ANTIVIRAL AGENT
    Publication number: 20100010080
    Abstract: The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Application
    Filed: July 13, 2007
    Publication date: January 14, 2010
    Applicants: ECCO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • Trivalent vaccine with material antibody transfer via the milk
    Publication number: 20060140976
    Abstract: Embodiments of the present invention generally relate to novel multivalent vaccines and methods of vaccinating. In an embodiment, the present invention is a trivalent vaccine for canine herpesvirus (CHV), canine rotavirus (CRV), and Minute virus of canine (MVC) or other canine parvovirus delivered to pups of a whelp through colustrums and providing sufficient antibody titer to impart protection.
    Type: Application
    Filed: December 18, 2003
    Publication date: June 29, 2006
    Applicant: Akzo Nobel N.V.
    Inventors: Thomas Gore, Adrian Mockett